Sophia Genetics Stock Quote SOPH - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Sophia Genetics SA (SOPH) Quote

Sophia Genetics SA (SOPH)

5.03

0.08

(1.62%)

Closed April 28 4:00PM

Delayed by 15 minutes

5.03

0.00

(0.00%)

After Hours: 4:00PM

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

5.03

Bid

4.81

Ask

11.40

Volume

28,002

4.81 Day's Range 5.06

2.13 52 Week Range 7.37

Market Cap

Previous Close

4.95

Open

4.81

Last Trade

Last Trade Time

Financial Volume

$ 137,153

VWAP

4.898

Average Volume (3m)

62,421

Shares Outstanding

65,230,559

Dividend Yield

-

PE Ratio

-4.45

Earnings Per Share (EPS)

-1.13

Revenue

40.45M

Net Profit

-73.68M

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets an... Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. Show more

Sector

Cmp Processing,data Prep Svc

Industry

Cmp Processing,data Prep Svc

Website

www.sophiagenetics.com

Headquarters

Lausanne, Che

Founded

1970

Sophia Genetics SA is listed in the Cmp Processing,data Prep Svc sector of the NASDAQ with ticker SOPH. The last closing price for Sophia Genetics was $4.95. Over the last year, Sophia Genetics shares have traded in a share price range of $ 2.13 to $ 7.37.

Sophia Genetics currently has 65,230,559 shares outstanding. The market capitalization of Sophia Genetics is $328.11 million. Sophia Genetics has a price to earnings ratio (PE ratio) of -4.45.

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its...

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa PR Newswire BOSTON and ROLLE, Switzerland, April 23, 2024 Syndicate Bio to implement new liquid biopsy offering...

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD) PR Newswire BOSTON and ROLLE, Switzerland, April 17, 2024 European-based Unilabs...

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership PR Newswire BOSTON and ROLLE, Switzerland, April 4, 2024 The companies will join forces to advance the use of precision...

Laboratorio Barnafi-Krause is Live on SOPHiA DDM™

Laboratorio Barnafi-Krause is Live on SOPHiA DDM™ PR Newswire BOSTON and ROLLE, Switzerland, April 2, 2024 The Chile-based Laboratory is using SOPHiA GENETICS' platform to advance its research...

SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada

SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada PR Newswire BOSTON and ROLLE, Switzerland, March 20, 2024 University of Saskatchewan's (USask...

SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration

SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration PR Newswire BOSTON and ROLLE, Switzerland, March 15, 2024 New Multimodal...

SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference

BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief...

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.32	6.7940552017	4.71	5.25	4.71	58187	5.00395176	CS
4	0.11	2.23577235772	4.92	5.25	4.7	84758	4.96280415	CS
12	0.37	7.93991416309	4.66	7.37	4	62421	5.01665029	CS
26	1.35	36.6847826087	3.68	7.37	3.11	50957	4.76518417	CS
52	0.41	8.87445887446	4.62	7.37	2.13	52646	4.2105237	CS
156	-13.42	-72.7371273713	18.45	19.8	1.685	81927	7.15889052	CS
260	-13.42	-72.7371273713	18.45	19.8	1.685	81927	7.15889052	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.3254 (82.86%)	70.82M
IBRXImmunityBio Inc	$ 7.35 (43.84%)	40.28M
AGENAgenus Inc	$ 11.685 (40.78%)	3.37M
ULHUniversal Logistics Holdings Inc	$ 45.63 (38.74%)	484.22k
NIVFNewGenIvf Group Ltd	$ 1.77 (36.15%)	57.78M
MFImF International Ltd	$ 2.3153 (-77.82%)	21.23M
NWGLNature Wood Group Ltd	$ 5.05 (-70.03%)	2.48M
ICLKiClick Interactive Asia Group Ltd	$ 1.21 (-52.17%)	719.95k
NUWENewellis Inc	$ 0.1695 (-41.35%)	18.46M
SGBXSafe and Green Holdings Corporation	$ 0.1469 (-32.92%)	8.39M
PEGYPineapple Energy Inc	$ 0.065499 (26.20%)	325.57M
SQQQProShares UltraPro Short QQQ	$ 11.43 (-4.75%)	137.28M
INTCIntel Corporation	$ 31.88 (-9.20%)	119.84M
TSLATesla Inc	$ 168.29 (-1.11%)	109.84M
SOFISoFi Technologies Inc	$ 7.87 (3.69%)	88.63M

jbog

jbog 42 seconds ago

I sold a bunch of shares at $37 last year

So did I.

edcoolidge
Re: None
Tuesday, August 08, 2023 5:10:09 PM Stock around $20
Post# 4002 of 7207
I'm very reluctant to call a bottom but we may have seen it today during the AH. Major catalyst

Armadillo49

Armadillo49 1 minute ago

Thanks for your efforts, Eli.

gshores

gshores 1 minute ago

Are you being serious? You are grasping at straws now! Lol
Strickland is long gone, john bought the shell strickland is long gone!
You used to peak my interest, but now i can see you are trying everything you can to get the price down, good luck buddy we are heading straight up!!

infamous

infamous 2 minutes ago

Yes only if its not MTD. Coin doesn't know SHT about timelines

rosemountbomber

rosemountbomber 2 minutes ago

Don't know North. It would have to be some profound noticeable effect for the researchers to delve into it, as the study protocol and goals don't encompass such:

"The proposed study is a proof-of-concept, randomized, placebo-controlled, double-blind, parallel-group clinical trial ass

Tiger Money

Tiger Money 2 minutes ago

$1.57 warrants. Are they worth it? It isn’t my capital taking it to the promise land….I will ride the rip though

learningcurve2020

learningcurve2020 3 minutes ago

They've got Danish.

PickStocks

PickStocks 4 minutes ago

Problem with this is that Coburn is dead and no one to follow through……it was just words to appease his followers…

varmit

varmit 4 minutes ago

Isn’t just about may????

Where is that filing hiding ????

We need numbers ??????

Tiger Money

Tiger Money 4 minutes ago

Looking at the numbers I tend to agree. If you invested in this before, I completely get it. I almost feel like I’m picking up pennies up in front of a steam roller.

2014shelby

2014shelby 4 minutes ago

Looks like Transfer Agent Verified on OTCM. Interesting

williamssc

williamssc 5 minutes ago

Excellent
We thank William F. DeGrado, University of California, San Francisco, for his contributions to the development of the field of nonpeptide defensin mimetics, his interest in the initiation of these studies, and his critique of the manuscript.

This study was supported

Carjockey2

Carjockey2 5 minutes ago

No she enjoys her weekends with her family.

Simple as that!!

CJ is very quiet be cause of NO Verifiable DD about this Chinese wanta be share selling SCAM!!

getmoreshares

getmoreshares 6 minutes ago

lizzie borden https://twitter.com/Ginalilvol/status/1784694783639797913

oldstocks

oldstocks 7 minutes ago

A lot of posting by many over this weekend
$AFFU must be gaining interest

martymech

martymech 7 minutes ago

LOL with a big belly laugh.. whatever gets you through the day or night Casper.. What a .......lol I guess it's your turn in the ring for a while .. lol tag your it.. my oh my.. LOL JMO

ZenNavigator54

ZenNavigator54 8 minutes ago

LENZI which was bought for nothing to hgenq shareholders. Now in business, if assets are so below 'fair value' it can be void and buyer knows it's below fair value. I don't know what law that voids transactions. but if an asset was sold to cheap and sold to insiders it considere 'embezzlement' whic

ReikoBlack

ReikoBlack 9 minutes ago

You no longer want a Lexus?

Yes, I believe we will all do well.

At least, those who released. Don't think I want a Ferrari. But a vette will be nice.

bear777

bear777 9 minutes ago

Welcome to the wishing well. Just make sure to buy over 10 million shares and hope for the best. Wash , rinse and repeat! What happened to Master of Disaster? Did he bail out?

Tiger Money

Tiger Money 10 minutes ago

You finally used edit replace for otc to Nasdaq after you kept calling it an otc merger for some reason

The_Dohminator

The_Dohminator 10 minutes ago

Because we are the righteous. You just mad you can't block everyone like you do on the other boards. Rory Cutaia scams

Arturosurfer

Arturosurfer 10 minutes ago

This is a unicorn!!!

Sophia Genetics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions